Moore Capital Management, LP Clovis Oncology, Inc. Transaction History

Moore Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $734,250 - $1.24 Million	-25,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $288,450 - $422,900	-5,000 Reduced 16.67%	25,000 $1.7 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $2.02 Million - $2.54 Million	30,000	30,000 $2.47 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.